A comparative study by age and gender of the pituitary adenoma and ACTH and α-MSH secretion in dogs with pituitary-dependent hyperadrenocorticism

Research in Veterinary Science

Volumn 88, Issue 1, 2010, Pages 33-40

  Gallelli, M F ^a   Cabrera Blatter, M F ^b   Castillo, V ^b  

^a Facultad de Ciencias Veterinarias   (Argentina)

^b Htal Escuela de Medicina Veterinaria   (Argentina)

Author keywords

Corticotrophinoma; Cushing's disease; Hypercortisolism; Pituitary adenoma; Pituitary dependent hyperadrenocorticism

Indexed keywords

ALPHA INTERMEDIN; CORTICOTROPIN; HYDROCORTISONE;

AGE DISTRIBUTION; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASE; CUSHING DISEASE; DIAGNOSTIC IMAGING; FEMALE; HORMONE RELEASE; HYDROCORTISONE URINE LEVEL; HYPERADRENOCORTICISM; HYPERCORTISOLISM; HYPOPHYSIS ADENOMA; HYPOPHYSIS INTERMEDIATE LOBE; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SELLA TURCICA TUMOR; SEX DIFFERENCE; TUMOR VOLUME;

ACTH-SECRETING PITUITARY ADENOMA; ADRENOCORTICAL HYPERFUNCTION; ADRENOCORTICOTROPIC HORMONE; AGE FACTORS; ALPHA-MSH; ANIMALS; DOG DISEASES; DOGS; FEMALE; MAGNETIC RESONANCE IMAGING; MALE; PITUITARY GLAND; PITUITARY NEOPLASMS; RETROSPECTIVE STUDIES; SEX FACTORS;

CANIS FAMILIARIS;

EID: 71949101517     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2009.06.011     Document Type: Article

References (58)

1. Antoni F.A. Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocrine Reviews 7 (1986) 351-378
2. Asa S.L., and Ezzat S. The cytogenesis and pathogenesis of pituitary adenomas. Endocrine Reviews 19 (1998) 798-827
3. Atkinson H.C., and Waddell B.J. Circadian variation in basal plasma corticosterone and adrenocorticotropin in the rat: sexual dimorphism and changes across the estrous cycle. Endocrinology 138 (1997) 3842-3848
4. Beijerink N.J., Bhatti S.F.M., Okkens A.C., Dieleman S.J., Mol J.A., Duchateau L., Van Hamb L.M.L., and Kooistra H.S. Adenohypophyseal function in bitches treated with medroxyprogesterone acetate. Domestic Animal Endocrinology 32 (2007) 63-78
5. Bertoy E.H., Feldman E.C., Nelson R.W., Duesberg C.A., Kass P.H., Reid M.H., and Dublin A.B. Magnetic resonance imaging of the brain in dogs with recently diagnosed but untreated pituitary-dependent hyperadrenocorticism. Journal of the American Veterinary Medical Association 206 (1995) 651-656
6. Bosje J., Rijnberk A., Mol J., Voorhout G., and Kooistra H. Plasma concentrations of ACTH precursors correlate with pituitary size and resistance to dexamethasone in dogs with pituitary-dependent hyperadrenocorticism. Domestic Animal Endocrinology 22 (2002) 201-210
7. Burgess L.H., and Handa R.J. Chronic estrogen-induced alterations in adrenocorticotropin and corticosterone secretion, and glucocorticoid receptor-mediated functions in female rats. Endocrinology 131 (1992) 1261-1269
8. Cannavó S., Almota B., Dall'Asta C., Corsello S., Lovicu RM., De Menis E., Trimarchi F., and Ambrosi B. Long-term results of treatment in patients with ACTH-secreting pituitary macroadenomas. European Journal of Endocrinology 149 (2003) 195-200
9. Carey M.P., Deterd C.H., deKoning J., Helmerhorst F., and deKloe E.R. The influence of ovarian steroids on hypothalamic-pituitary-adrenal regulation in the rat. Journal of Endocrinology 144 (1995) 311-321
10. Castillo V.A., Giacomini D.P., Paez-Pered M., Stalla J., Labeur M., Theodoropoulou M., Holsboer F., Grossman A., Stalla G., and Arzt E. Retinoic acid as a novel medical therapy for Cushing's disease in dogs. Endocrinology 174 (2006) 4438-4444
11. Castillo V.A., Gomez N.V., Lalia J.C., Cabrera Blatter M.F., and Garcia J.D. Cushinǵs disease in dogs: Cabergoline treatment. Research in Veterinary Science 85 (2008) 26-34
12. Colao A., Lombardi G., and Annunziato L. Cabergoline. Experimental Opinion Pharmacotherapy 1 (2000) 555-574
13. Dahia P.L., and Grossman A.B. The molecular pathogenesis of corticotroph tumors. Endocrinology Review 20 (1999) 136-155
14. de Bruin C., Hanson J.M., Meij B.P., Kooistra H.S., Waaijers A.M., Uitterlinden P., Lamberts S.W.J., and Hofland L.J. Expression and functional analysis of dopamine receptor subtype 2 and somatostatin receptor subtypes in canine Cushing's disease. Endocrinology 149 (2008) 4357-4366
15. Don W., and Day R. Gene expression of proprotein convertases in individual rat anterior pituitary cells and their regulation in corticotrophs mediated by glucocorticoids. Endocrinology 143 (2002) 254-262
16. Duesberg C.A., Feldman E.C., Nelson R.W., Bertoy E.H., Dublin A.B., and Reid M.H. Magnetic resonance imaging for diagnosis of pituitary macrotumors in dogs. Journal of the American Veterinary Medical Association 206 (1995) 657-662
17. Filippa V., and Mohamed F. ACTH cells of pituitary pars distalis of viscacha (Lagostomus maximus maximus): Immunohistochemical study in relation to season, sex, and growth. General and Comparative Endocrinology 146 (2006) 217-225
18. Galac S., Kooistra H., Teske E., and Rijnberk A. Urinary corticoid/creatinine ratios in the differentiation between pituitary-dependent hyperadrenocorticism and hyperadrenocorticism due to adrenocortical tumour in the dog. Veterinary Quarterly 19 (1997) 17-20
19. Goy-Thollot I., Decosne-Junot C.h., and Bonnet J.M. Influence of aging on adrenal responsiveness in a population of eleven healthy beagles. Research in Veterinary Science 82 (2007) 195-201
20. Hanson J.M., Kooistra H.S., Mol J.A., Teske E., and Meij B.P. Plasma profiles of adrenocorticotropic hormone, cortisol, α-melanocyte-stimulating hormone, and growth hormone in dogs with pituitary-dependent hyperadrenocorticism before and alter hypophysectomy. Journal of Endocrinology 190 (2006) 601-609
21. Hereñú C., Cristina C., Rimoldi O., Becú-Villalobos D., Cambiaggi D., Portiansky E., and Goya R. Restorative effect of insulin-like growth factor-I gene therapy in the hypothalamus of senile rats with dopaminergic dysfunction. Gene Therapy 13 (2006) 1-9
22. Hullinger R.L. The endocrine system. In: Evans H.E. (Ed). Miller's Anatomy of the Dog. third ed. (1993), WB Saunders, Philadelphia 559-585
23. Kane L., Leinung M., Scheithauer BW., Bergstralh EJ., Laws E.R., Groover Jr. R.B., Kovacs K., Horvath E., and Zimmerman D. Pituitary adenomas in childhood and adolescence. Journal of Clinical Endocrinology and Metabolism 79 (1994) 1135-1140
24. Katznelson L., Bogan J.S., Trob J.R., Schoenfeld D.A., Hedley-White E.T., Hsu D.W., Zervas N.T., Swearingen B., Sleeper M., and Klibanski A. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas. Journal of Clinical Endocrinology and Metabolism 83 (1998) 1619-1623
25. Keller-Wood M. Evidence for reset of regulated cortisol in pregnancy: studies in adrenalectomized ewes. American Journal of Physiology 274 (1998) 145-151
26. Kemppainen RJ., and Sartin JL. Differential secretion of proopiomelanocortin peptides by the pars distalis and pars intermedia of beagle dogs. Journal of Endocrinology 117 (1988) 91-96
27. Kipp M., Karakaya S., Pawlak J., Araujo-Wright G., Arnold S., and Beber C. Estrogen and the development and protection of nigrostriatal dopaminergic neurons: concerted action of a multitude of signals, protective molecules. And growth factors Frontiers in Neuroendocrinology 27 (2006) 376-390
28. Kooistra H., Voorhout G., Mol J., and Rijnberk A. Correlation between impairment of glucocorticoid feedback and the size of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism. Journal of Endocrinology 152 (1997) 387-394
29. Korogi Y., and Mutsumasa T. Current concepts of imaging in patients with pituitary/hypothalamic dysfunction. Seminars in Ultrasound, CT, and MRI 16 (1995) 270-278
30. Lambrecht L., and Rubens R. MRI signal intensity profiles of sellar and perisellar lesions. Acta Clinica Bélgica Journal 44 (1989) 303-310
31. Laurent V., Kimble A., Peng B., Zhu P., Pintar JE., Steiner DF., and Lindberg I. Mortality in 7B2 null mice can be rescued by adrenalectomy: involvement of dopamine in ACTH hypersecretion. Proceedings of the National Academy of Sciences USA 99 (2002) 3087-3092
32. Leinung M.C., Kane L.A., Scheithauer B.W., Carpenter P.C., Laws Jr. E.R., and Zimmerman D. Long term follow-up of transsphenoidal surgery for the treatment of Cushing's disease in childhood. Journal of Clinical Endocrinology and Metabolism 80 (1995) 2475-2479
33. Levy A., and Lightman S. Molecular defects in the pathogenesis of pituitary tumours. Frontiers in Neuroendocrinology 24 (2003) 94-127
34. Ling G., Stabenfeldt G., Comer K., Gribble D., and Schechter R. Canine hyperadrenocorticism: pre-treatment clinical and laboratory evaluation of 117 cases. Journal of the American Veterinary Medical Association 174 (1979) 1211-1215
35. Losa M., Barzaghi R., Mortini P., Franzin A., Mangili F., Terreni MR., and Giovanelli M. Determination of the proliferation and apoptotic index in adrenocorticotropin-secreting pituitary tumors. Comparison between micro and macroadenomas. American Journal of Pathology 156 (2000) 245-251
36. Meij B.P., Mol J.A., Van den Ingh T.S.G.A.M., Bevers M.M., Hazewinkel H.A., and Rijnberk A. Assessment of pituitary function after transsphenoidal hypophysectomy in beagle dogs. Domestic Animal Endocrinology 14 (1997) 81-97
37. Meij B.P., Mol J.A., Bevers M.M., and Rijnberk A. Alterations in anterior pituitary function of dogs with pituitary-dependent hyperadrenocorticism. Journal of Endocrinology 154 (1997) 505-512
38. Melmed S. Mechanisms for pituitary tumorigenesis: the plastic pituitary. Journal of Clinical Investigation 112 (2003) 1603-1618
39. Mu Y.-M., Takayanagi R., Imasaki K., Ohe K., Ikuyama S., Yanase T., and Nawata H. Low level of glucocorticoid receptor messenger ribonucleic acid in pituitary adenomas manifesting Cushing's disease with resistance to a high dose dexamethasone suppression test. Clinical Endocrinology (Oxf) 49 (1998) 301-306
40. Munemura M., Cote T., Tsuruta K., Eskay R., and Kebabian J. The dopamine receptor in the intermediate lobe of the rat anterior pituitary gland: pharmacological characterization. Endocrinology 106 (1980) 1676-1683
41. Ohlerth S., and Scharf G. Computed tomography in small animals - basic principles and state of the art applications. The Veterinary Journal 173 (2007) 254-271
42. Oishi Y., Okuda M., Takahashi H., Fujii T., and Morii S. Cellular proliferation in the anterior pituitary gland of normal adult rats: influences of sex, estrous cycle and circadian change. Anatomical Record 235 (1993) 111-120
43. Peterson M.E., Orth D.N., Halmi N.S., Zielinski A.C., Davis D.R., Chavez F.T., and Drucker W.D. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Addison's disease and Cushing's syndrome: basal concentrations. Endocrinology 119 (1986) 720-730
44. Pivonello R., Ferone D., de Herder W., Kros J., del basso de Caro M., Arvigo M., Annunziato L., Lombardi G., Colao A., Hofland L., and Lamberts S. Dopamine receptor expression and function in corticotroph pituitary tumors. Journal of Clinical Endocrinology and Metabolism 89 (2004) 2452-2462
45. Reul J.M., Rothuizen J., and de Kloet E.R. Age-related changes in the dog hypothalamic-pituitary-adrenocortical system: neuroendocrine activity and corticosteroid receptors. The Journal of Steroid Biochemistry and Molecular Biology 40 (1991) 63-69
46. Rijnberk A., Van Wees A., and Mol J. Assessment of two tests for the diagnosis of canine hyperadrenocorticism. Veterinary Research 122 (1988) 178-180
47. Rothuizen J. Aging and the hypothalamus-pituitary-adrenocortical axis, with special reference to the dog. Acta Endocrinologica 125 (1991) 73-76
48. Rothuizen J., Reul J.M., Van Sluijs F.J., Mol J.A., Rijnberk A., and de Kloet E.R. Increased neuroendocrine reactivity and decreased brain mineralocorticoid receptor binding capacity in aged dogs. Endocrinology 132 (1993) 161-168
49. Saiardi A., Bozzi Y., Ja-Hyun Baik J., and Borrelli E. Antiproliferative role of dopamine: loss of D2 receptors causes hormonal dysfunction and pituitary hyperplasia. Neuron 19 (1997) 115-126
50. Selvais P., Donckier J., Buysschaert M., and Maiter D. Cushing's disease: a comparison of pituitary corticotroph microadenomas and macroadenomas. European Journal of Endocrinology 138 (1998) 153-159
51. Speert D., McClennen S., and Seasholtz A. Sexually dimorphic expression of corticotropin-releasing hormone-binding protein in the mouse pituitary. Endocrinology 143 (2002) 4730-4741
52. Tanaka S. Comparative aspects of intracellular proteolytic processing of peptide hormone precursors: studies of proopiomelanocortine processing. Zoological Science 20 (2003) 1183-1198
53. Van der Vlugt-Meijer R.H., Voorhout G., and Meij B.P. Imaging of the pituitary gland in dogs with PDH. Molecular and Cellular Endocrinology 197 (2002) 81-87
54. Van der Vlugt-Meijer R.H., Meij B.P., Van den Ingh T.S., Rijnberk A., and Voorhout G. Dynamic computed tomography of the pituitary gland in dogs with pituitary17 dependent hyperadrenocorticism. Journal of Veterinary Internal Medicine 17 (2003) 773-780
55. Vidal S., Roman A., and Moya L. Inmunohistochemical identification and morphometric study of ACTH cells of mink (Mustela vison) during growth and different stages of sexual activity in the adult. General and Comparative Endocrinology 100 (1995) 18-26
56. Voutetakis A., Argropoulou M., Sertedaki A., Livadas S., Xekouki P., Maniati-Christidi M., Bossis I., Thalassinos N., Patronas N., and Dacou-Voutetakis C. Pituitary magnetic resonance imaging in 15 patients with prop1 gene mutations: pituitary enlargement may originate from the intermediate lobe. Journal of Clinical Endocrinology and Metabolism 89 (2004) 2200-2206
57. Westphal C.H., Muller L., Zhou A., Bonner-Weir S., Schambelan M., Steiner D.F., Lindberg I., and Leder P. The neuroendocrine protein 7B2 is required for peptide hormone processing in vivo and provides a novel mechanism for pituitary Cushing's disease. Cell 96 (1999) 689-700
58. Zhou A., Bloomquist B.T., and Mains R.E. The prohormone convertases PC1 and PC2 mediate distinct endoproteolytic cleavages in a strict temporal order during pro opiomelanocortin biosynthetic processing. The Journal of Biological Chemistry 268 (1993) 1763-1769